Ixekizumab

Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis

Ixekizumab Diabetes Intervention Trial (I-DIT)

A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody Therapy

A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis

Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight

Utilization of a Microdevice for Psoriasis and Atopic Dermatitis

Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight

Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India

Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms

Targeting IL-17A for Treatment-Resistant Depression

COVID-19 VaccinE Response in Rheumatology Patients

Efficacy and Safety of Ixekizumab in Patients with Refractory Guttate Psoriasis

Ixekizumab Versus Secukizumab in Over 70-year-old Patients with Psoriasis

An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum

A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial Spondyloarthritis

Study of Ixekizumab in Healthy Participants

Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis